Late Treatment Effects and Cancer Survivor...

Dekorationsartikel gehören nicht zum Leistungsumfang.

Sprache: Englisch

209,95 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 1-2 Wochen

Kategorien:

Der Artikel ist nicht in deutscher Sprache verfasst.
Die Sprache der Produktbeschreibung und Details kann in Englisch angegeben sein. Sollten Sie Verständnisprobleme haben, wenden Sie sich gerne an uns.

Beschreibung

This comprehensive guide describes the aftercare that is appropriate in young cancer patients and discusses in detail the risk and detection of treatment sequelae. It explains the impacts on body and mind of both the disease itself and the different risk-adapted cancer treatments currently in use. Clear guidance is provided on diagnosis and management of the principal treatment-related toxicities in different organs and organ systems and for a wide variety of tumor types. In addition, the role of genetic polymorphisms in the development of adverse therapy-related outcomes is explored, and advice offered on genetic counselling. As the number of long-term survivors of childhood cancer and of cancer in young adults continues to grow, so issues surrounding potential sequelae, second malignancies, and quality of life are becoming ever more important. All practitioners involved in the care of young cancer patients will find this book to be a helpful source of up-to-date information andassistance.

Zusammenfassung

Offers clear guidance on cancer aftercare and the diagnosis and management of treatment-related toxicities in the young

Covers the full range of organs, organ systems, settings, and tumor types

Explores the role of genetic polymorphisms in adverse therapy-related outcomes

Inhaltsverzeichnis

Chapter 1. Cardiotoxicity after Childhood Cancer Treatment.- Chapter 2. Kidney.- Chapter 3. Ototoxicity after Childhood Cancer Treatment.- Chapter 4. Complications in tumour orthopaedics.- Chapter 5. Causes and course of (severe) late effects - GI tract.- Chapter 6. Pulmonary toxicity - Causes and course of (severe) late effects in the Lungs.- Chapter 7. Growth hormone deficiency in adult childhood cancer survivors.- Chapter 8. Endocrine Late Effects - Thyroid Gland .- Chapter 9. Disorders of gonadal and reproductive function in survivors of childhood cancer.- Chapter 10. Fertility protection in childhood, adolescents and young adulthood cancer patients.- Chapter 11. Endocrine Late Effects - Adrenal Gland .- Chapter 12. Pregnancy and Birth.- Chapter 13. Endocrine Late Effects - Obesity and Metabolic Syndrome after Childhood Cancer.- Chapter 14. Subsequent primary cancer after childhood, teenage and young adult cancer.- Chapter 15. Diagnostic of Late Treatment effects: Neuropsychological Short Assessment of Disease- and Treatment-related Intelligence Deficits in Children with Brain Tumors .- Chapter 16. Long-term Positive and Negative Psychosocial Outcomes in Young Childhood Cancer Survivors and their Healthy Peers - Posttraumatic Stress Disorder / Somatoform Disorder.- Chapter 17. Cancer related fatigue .- Chapter 18. Late effects after treatment of acute lymphoblastic leukemia in childhood and adolescence.- Chapter 19. Late effects after treatment of acute myeloic leukemia .- Chapter 20. Side Effects and Sequelae of Treatment for Chronic Myeloid Leukemia in Childhood and Adolescence.- Chapter 21. Late e¿ects after treatment of Non-Hodgkin lymphoma in childhood and adolescents.- Chapter 22. Late e¿ects after treatment of Hodgkin lymphoma.- Chapter 23. Langerhans Cell Histiocytosis.- Chapter 24. Diagnostics and Diagnosis of Late Effects

in Childhood Brain Tumour Survivors.- Chapter 25. Late effects in children and adolescents with neuroblastoma.- Chapter 26. Late effects in children and adolescents with nephroblastoma.- Chapter 27. Hepatoblastoma and Hepatocellular Carcinoma.- Chapter 28. Long Term Sequelae after retinoblastoma .- Chapter 29. Late effects in children and adolescents with Ewing Sarcoma.- Chapter 30. Late effects in children and adolescents with osteosarcoma.- Chapter 31. Late effects in children and adolescents with soft tissue sarcoma.- Chapter 32. Potential late effects of rhabdoid tumor therapy.- Chapter 33. Late effects after treatment of malignant endocrine tumors.- Chapter 34. Skin cancer - treatment and implications for the long term follow up.- Chapter 35. Breast Cancer.- Chapter 36. Colorectal carcinoma .- Chapter 37. Genetic predisposition to late effects - pharmacogenomics of cisplatin-induced ototoxicity.- Chapter 38. Physical activity, exercise, and sports.- Chapter 39. Late effects after radiotherapy.- Chapter 40. Long-Term Follow-Up from the Point of View of a Person A¿ected.- Chapter41. Networks of Survivorship Care.

Details

Erscheinungsjahr:	2020
Fachbereich:	Andere Fachgebiete
Genre:	Medizin
Rubrik:	Wissenschaften
Medium:	Buch
Inhalt:	viii 439 S. 13 s/w Illustr. 33 farbige Illustr. 439 p. 46 illus. 33 illus. in color.
ISBN-13:	9783030491383
ISBN-10:	3030491382
Sprache:	Englisch
Ausstattung / Beilage:	HC runder Rücken kaschiert
Einband:	Gebunden
Redaktion:	Beck, Jörn D. Langer, Thorsten Bokemeyer, Carsten
Herausgeber:	Jörn D Beck/Carsten Bokemeyer/Thorsten Langer
Auflage:	1st ed. 2021
Hersteller:	Springer International Publishing Springer International Publishing AG
Maße:	260 x 183 x 28 mm
Von/Mit:	Jörn D. Beck (u. a.)
Erscheinungsdatum:	06.11.2020
Gewicht:	1,135 kg

Artikel-ID: 118283540